Galectin-3 Monoclonal Antibody(16E6)

This gene encodes a member of the galectin family of carbohydrate binding proteins. Members of this protein family have an affinity for beta-galactosides. The encoded protein is characterized by an N-terminal proline-rich tandem repeat domain and a single C-terminal carbohydrate recognition domain. This protein can self-associate through the N-terminal domain allowing it to bind to multivalent saccharide ligands. This protein localizes to the extracellular matrix, the cytoplasm and the nucleus. This protein plays a role in numerous cellular functions including apoptosis, innate immunity, cell adhesion and T-cell regulation. The protein exhibits antimicrobial activity against bacteria and fungi. Alternate splicing results in multiple transcript variants.

Introducing the GALECTIN-3 Monoclonal Antibody (16E6), a cutting-edge product designed to revolutionize the field of immunotherapy. This highly advanced monoclonal antibody is meticulously engineered to target and neutralize the galectin-3 protein, a key player in various pathological processes.

The GALECTIN-3 Monoclonal Antibody (16E6) boasts exceptional specificity and affinity, ensuring precise and effective binding to galectin-3. Its unique formulation enables it to penetrate cellular barriers and engage with the protein, thereby inhibiting its detrimental effects. This antibody's remarkable potency and selectivity make it an invaluable tool for researchers and clinicians alike.

With its unrivaled performance, the GALECTIN-3 Monoclonal Antibody (16E6) holds immense potential in the development of novel therapeutic strategies. By targeting galectin-3, this antibody opens up new avenues for the treatment of various diseases, including cancer, fibrosis, and inflammation. Its versatility extends to diagnostic applications, facilitating the identification and monitoring of galectin-3 levels in patients.

Crafted with utmost precision and adhering to the highest quality standards, the GALECTIN-3 Monoclonal Antibody (16E6) guarantees reproducibility and reliability in experimental settings. Its exceptional stability and long shelf life ensure consistent performance, enabling researchers to achieve accurate and meaningful results.

Embrace the future of immunotherapy with the GALECTIN-3 Monoclonal Antibody (16E6). Unlock the potential of galectin-3 inhibition and pave the way for groundbreaking advancements in the field of biomedical research and clinical practice.